A
AbCellera Biologics Inc. (ABCL)
NMS – Real Time Price. Currency in USD
4.95
-0.30 (-5.71%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
4.95
-0.30 (-5.71%)
At close: May 12, 2026, 4:00 PM EDT
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
| Name | Position |
|---|---|
| Caitlin Webster CIPD, M.Sc. | Director of Talent Development |
| Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson |
| Dr. Veronique Lecault Ph.D. | CTO & Director |
| Mr. Adam Clarke M.A.I.C.D., Ph.D. | Senior Vice President of Discovery |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer |
| Mr. Andrew Knowles M.Sc. | Vice President of Operations |
| Mr. Martin Hogan M.Sc. | Senior Director of Strategic Finance & IR |
| Mr. Murray McCutcheon Ph.D. | Senior Vice President of Partnering |
| Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer |
| Ms. Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | DEFA14A | defa14a.htm |
| 2026-04-29 | ARS | annualreport.pdf |
| 2026-02-24 | S-8 | abcellera-formsx82026.htm |
| 2026-02-24 | 10-K | abcl-20251231.htm |
| 2026-01-14 | 8-K | abcl-20260112.htm |
| 2025-12-18 | 8-K | abcl-20251218.htm |
| 2025-11-28 | 8-K | abcl-20251124.htm |
| 2025-11-12 | 8-K | abcl-20251110.htm |
| 2025-11-06 | 8-K | abcl-20251106.htm |
| 2025-09-10 | 8-K | abcl-20250910.htm |